Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Incorporation of
H2A
.Z into the chromatin of inactive promoters has been shown to poise genes for their expression. Here we provide strong evidence that
H2A
.Z is incorporated into the promoter regions of estrogen receptor (ERalpha) target genes only upon gene induction, and that, in a cyclic pattern. Moreover, members of the human
H2A
.Z-depositing complex, p400, also follow the same gene recruitment kinetics as
H2A
.Z. Importantly, cellular depletion of
H2A
.Z or p400 leads to a severe defect in estrogen signaling, including loss of estrogen-specific cell proliferation. We find that incorporation of
H2A
.Z within
TFF1
promoter chromatin allows nucleosomes to adopt preferential positions along the DNA translational axis. Finally, we provide evidence that
H2A
.Z is essential to allow estrogen-responsive enhancer function. Taken together, our results provide strong mechanistic insight into how
H2A
.Z regulates ERalpha-mediated gene expression and provide a novel link between
H2A
.Z-p400 and ERalpha-dependent gene regulation and enhancer function.
...
PMID:Histone H2A.Z is essential for estrogen receptor signaling. 1951 75